Involvement of brain serotonin in the stimulant action of amphetamine and of cholinolytics.
D006916:5-Hydroxytryptophan / Q000494:pharmacology; D000661:Amphetamine / Q000037:antagonists & inhibitors*; D000818:Animals; D001285:Atropine / Q000037:antagonists & inhibitors; D001535:Benactyzine / Q000037:antagonists & inhibitors; D001921:Brain / Q000502:physiology*; D001923:Brain Chemistry / Q000187:drug effects; D004336:Drug Antagonism; D004357:Drug Synergism; D005260:Female; D010134:Fenclonine / Q000494:pharmacology; D008124:Locomotion / Q000187:drug effects; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology*; D008297:Male; D008747:Methylcellulose / Q000494:pharmacology; D008784:Methysergide / Q000494:pharmacology*; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D009638:Norepinephrine / Q000378:metabolism; D010649:Phenylalanine / Q000494:pharmacology*; D011955:Receptors, Drug; D012701:Serotonin / Q000032:analysis / Q000502:physiology*; D012702:Serotonin Antagonists; D013268:Stimulation, Chemical
D011955:Receptors, Drug; D012702:Serotonin Antagonists; D012701:Serotonin; D010649:Phenylalanine; D001535:Benactyzine; D001285:Atropine; D008238:Lysergic Acid Diethylamide; D008747:Methylcellulose; D006916:5-Hydroxytryptophan; D000661:Amphetamine; D010134:Fenclonine; D009638:Norepinephrine; D008784:Methysergide